Loading…
MIRA Pharmaceuticals, Inc. is projected to rise to $0.7411 by 2027, a +21% move from its current price of $0.6139. MIRA is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $0.5985 | $0.614 | $0.63 | +0.02% |
| Aug 6 | $0.5922 | $0.6141 | $0.6368 | +0.04% |
| Aug 7 | $0.5875 | $0.6142 | $0.6421 | +0.05% |
| Aug 8 | $0.5836 | $0.6143 | $0.6467 | +0.07% |
| Aug 9 | $0.5802 | $0.6145 | $0.6507 | +0.09% |
| Aug 10 | $0.5771 | $0.6146 | $0.6544 | +0.11% |
| Aug 11 | $0.5743 | $0.6147 | $0.6579 | +0.13% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.5743 | $0.6147 | $0.6579 | +0.13% |
| Week 2 | $0.5591 | $0.6155 | $0.6775 | +0.25% |
| Week 3 | $0.5479 | $0.6162 | $0.6931 | +0.38% |
| Week 4 | $0.5387 | $0.617 | $0.7067 | +0.51% |
| Week 5 | $0.5308 | $0.6178 | $0.7191 | +0.64% |
| Week 6 | $0.5238 | $0.6186 | $0.7305 | +0.76% |
| Week 7 | $0.5175 | $0.6194 | $0.7412 | +0.89% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
MIRA Pharmaceuticals, Inc. operates as a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders. The company holds exclusive U.S., Canadian, and Mexican rights for Ketamir-2, a next-generation oral NMDA receptor modulator, that has completed a Phase 1 clinical trial.
It also offers oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia; and SKNY-1, that is in preclinical stage for obesity and nicotine dependence. The company was incorporated in 2020 and is based in Miami, Florida.
MIRA Pharmaceuticals, trading under the symbol MIRA, is currently priced at $0.8163 with a market capitalization of $35.37M. The company sits at rank 5307 by market cap percentile in the public markets. This positioning reflects a small-cap profile with significant volatility potential given its stage and program slate.
A major level 5.3% above — losing it would weaken the trend.
Support has flipped 29.0% overhead — reclaiming it would be bullish.
The nearest ceiling, 64.5% above — a clean break opens room to run.
A major ceiling 88.1% above — clearing it would confirm fresh momentum.
Key MIRA support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of MIRA market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.8344 | Sell | $0.8313 | Sell |
| MA 10 | $0.8747 | Sell | $0.861 | Sell |
| MA 20 | $0.9026 | Sell | $0.8917 | Sell |
| MA 50 | $0.9524 | Sell | $0.9425 | Sell |
| MA 100 | $1.00 | Sell | $1.02 | Sell |
| MA 200 | $1.21 | Sell | $1.13 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 28.08 | Buy |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -203.68 | Sell |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -0.01 | Sell |
| ROC (12) | -15.74 | Sell |
| Bollinger %B (20,2) | -0.11 | Buy |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | -0.34 | Sell |
| Awesome (5,34) | -0.09 | Sell |
| Ultimate (7,14,28) | 13.66 | Buy |
| Momentum (10) | -0.17 | Sell |
| Aroon Osc (25) | -96.00 | Sell |
| Hull MA (9) | 0.80 | Sell |
| ADX (14) | 18.36 | Neutral |
| ATR (14) | 0.02 | Info |
The near-term technical picture remains BEARISH. RSI14 is 30, signaling limited upside momentum in the immediate horizon. The stock trades near support at $0.816 and faces resistance at $1.01, with the 50-day simple moving average at $0.9556 and the 200-day simple moving average at $1.21.
The 30-day price range spans $0.6884 to $0.9679, underscoring the tight trading band around the current price. Annualized volatility sits near 50%, highlighting elevated risk in the short term.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.6139 | $0.6139 | $0.8116 | 0% | Neutral | |
| $0.5944 | $0.7411 | $0.9747 | +21% | Bullish | |
| $0.604 | $0.7732 | $1.05 | +26% | Bullish | |
| $0.5855 | $0.766 | $1.07 | +25% | Bullish | |
| $0.5953 | $0.7939 | $1.14 | +29% | Bullish | |
| $0.5711 | $0.775 | $1.13 | +26% | Bullish | |
| $0.5844 | $0.8059 | $1.20 | +31% | Bullish | |
| $0.6804 | $0.9526 | $1.44 | +55% | Bullish | |
| $0.7506 | $1.07 | $1.64 | +74% | Bullish | |
| $0.7713 | $1.11 | $1.73 | +81% | Bullish | |
| $0.9213 | $1.41 | $2.34 | +130% | Bullish | |
| $1.37 | $2.33 | $4.22 | +280% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $0.6139 | $0.6139 | $0.741 | +0.00% |
| September 2026 | $0.5169 | $0.6101 | $0.7395 | -0.61% |
| October 2026 | $0.5254 | $0.6241 | $0.7642 | +2.29% |
| November 2026 | $0.546 | $0.652 | $0.805 | +4.47% |
| December 2026 | $0.5439 | $0.6526 | $0.8116 | +0.09% |
Click any year to see its month-by-month MIRA forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The MIRA price prediction for 2026 points to an average of $0.6139 (low $0.6139, high $0.8116) — a potential gain of 0% on today's $0.6139. Price action looks broadly range-bound.
In 2027, MIRA is projected to trade between $0.5944 and $0.9747, averaging $0.7411 — a potential gain of +21% from today's $0.6139. That is up +21% on the projected 2026 average. Buyers look set to stay in control over this stretch.
MIRA Pharmaceuticals, Inc.'s 2028 outlook centres on $0.7732, within a $0.604 to $1.05 range. That is up +4% on the projected 2027 average. That marks a +26% change versus current levels. Momentum favours further upside here.
By 2029, MIRA could reach as high as $1.07, with a base case around $0.766 and support toward $0.5855 — roughly +25% from $0.6139. Buyers look set to stay in control over this stretch.
Expect MIRA to range from $0.5953 to $1.14 through 2030. The $0.7939 average target implies a +29% move from current prices. That is up +4% on the projected 2029 average. Momentum favours further upside here.
The MIRA price prediction for 2031 points to an average of $0.775 (low $0.5711, high $1.13) — a potential gain of +26% on today's $0.6139. Buyers look set to stay in control over this stretch.
In 2032, MIRA is projected to trade between $0.5844 and $1.20, averaging $0.8059 — a potential gain of +31% from today's $0.6139. That is up +4% on the projected 2031 average. Momentum favours further upside here.
MIRA Pharmaceuticals, Inc.'s 2033 outlook centres on $0.9526, within a $0.6804 to $1.44 range. That is up +18% on the projected 2032 average. That marks a +55% change versus current levels. Buyers look set to stay in control over this stretch.
By 2034, MIRA could reach as high as $1.64, with a base case around $1.07 and support toward $0.7506 — roughly +74% from $0.6139. Momentum favours further upside here.
Expect MIRA to range from $0.7713 to $1.73 through 2035. The $1.11 average target implies a +81% move from current prices. That is up +4% on the projected 2034 average. Buyers look set to stay in control over this stretch.
The MIRA price prediction for 2040 points to an average of $1.41 (low $0.9213, high $2.34) — a potential gain of +130% on today's $0.6139. Momentum favours further upside here.
In 2050, MIRA is projected to trade between $1.37 and $4.22, averaging $2.33 — a potential gain of +280% from today's $0.6139. That is up +65% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in MIRA today (≈ 1,628.929793 MIRA) could be worth
$3,802.21
+$2,802.21 (+280%) by 2050 · US Dollar
Based on the average projected MIRA price of $2.33 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in MIRAwould be worth at today's price.
$1,000 invested in MIRA on Jul 31, 2025 (≈ 606.060615 MIRA) would be worth
$372.06
-$627.94 (-62.8%) today · 0.37× · US Dollar
Based on a MIRA entry price of $1.65 vs. today's $0.6139.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.882 | $696.03 | -30.4% |
| 1 month ago | $0.947 | $648.26 | -35.2% |
| 3 months ago | $1.04 | $590.29 | -41.0% |
| 6 months ago | $1.21 | $507.36 | -49.3% |
| 1 year ago | $1.65 | $372.06 | -62.8% |
| All time (3.0y) ago | $7.42 | $82.74 | -91.7% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our MIRA forecast.
Our base-case forecast reaches $1.20 around 2040.
Implied market cap at $1.20: $50.43M
The multi-year forecast shows a bullish trajectory beginning in 2027 and extending through 2050. In 2026 the average price is $0.8163 with a neutral sentiment and a min of $0.816 and a max of $1.09. By 2027 the average rises to $0.9938 with a max of $1.31 and an ROI of 21.7% as sentiment shifts to bullish.
Through 2028 the average is $1.04 (max $1.42, ROI 27.7%), and 2029 carries an average of $1.03 (max $1.45, ROI 26.5%). In 2030 the forecasted average reaches $1.08 with a max of $1.56 and a 32.9% ROI, remaining bullish. The 2031–2032 period shows averages around $1.07–$1.12 with notable max prices up to $1.68 and continued bullish sentiment.
By 2033 the average is $1.35 and the max $2.06 (ROI 65.9%), and 2034–2035 show further strength (avg $1.50 and $1.55; max $2.32 and $2.43; ROI 84% and 90%). The ascent accelerates toward 2040, where the average is $2.05 and the max $3.40 (ROI 150.7%), with sentiment remaining bullish. By 2050, the forecast average rises to $3.36 with a max of $6.09 (ROI 311.8%), underscoring a strong long-run bullish thesis despite near-term uncertainty.
Tap a question to reveal the answer.
The forecast shows a 2030 average of $1.08 with a min of $0.8121, a max of $1.56, and a projected ROI of 32.9% with bullish sentiment.
Forecasts indicate a bullish path from 2027 onward, with the average price rising to $0.9938 in 2027, $1.04 in 2028, and $3.36 on average by 2050, along with a maximum implied ROI of up to 311.8% in 2050. These are estimates, not guarantees.
Yes. The forecast shows max prices above $2 in several years, including $2.06 in 2033, $2.32 in 2034, $2.43 in 2035, and $3.40 as a max in 2040.
The current price is $0.8163 and the market cap is $35.37M. The stock is ranked 5307 by market capitalization.
The near-term forecast for 2026 shows a neutral sentiment with an average of $0.8163, a min of $0.816, and a max of $1.09. RSI and volatility suggest caution, while longer-term indicators point to a bullish trajectory starting in 2027.
MIRA Pharmaceuticals, Inc. Community Discussion
0Share your MIRA Pharmaceuticals, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.